(Q34545371)

English

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

chemoradiotherapy

0 references

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

Andrew D Zelenetz

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Joachim Yahalom

6

object named as

Joachim Yahalom

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

author name string

Craig H Moskowitz

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Tarun Kewalramani

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Stephen D Nimer

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Maria Gonzalez

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

British Journal of Haematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

124

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

645-652

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871252%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

F-18-FDG uptake in tuberculosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Primary treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2003.04828.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34545371&oldid=1970206551"